Repare Therapeutics Inc.
News
HC Wainwright Weighs in on Repare Therapeutics Inc.'s Q3 2024 Earnings (NASDAQ:RPTX)
Zolmax Repare Therapeutics Inc. (NASDAQ:RPTX - Free Report) - Research analysts at HC Wainwright cut their Q3 2024 earnings per share (EPS) estimates for shares of Repare Therapeutics in a report released...\n more…
Repare Therapeutics (NASDAQ:RPTX) Given Buy Rating at HC Wainwright
Ticker Report HC Wainwright reaffirmed their buy rating on shares of Repare Therapeutics (NASDAQ:RPTX - Free Report) in a report issued on Wednesday, Benzinga reports. HC Wainwright currently has a $10.00 price...\n more…
Buy Rating on Repare Therapeutics Amidst Promising Clinical Trials and Strong Financials
TipRanks Financial Blog In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on Repare Therapeutics (RPTX - Research Report), with a price ...\n more…
Five things: Dell revenue; Gen X retirement and how (not) to make a toaster from scratch
BizJournals.com - Nat'l Business News Good morning. Here are five things you need to know in Boston business news today, plus what a book about a guy who tried to lake a toaster says about working as part of a team.\n more…
Stifel Nicolaus Reaffirms Their Buy Rating on Repare Therapeutics (RPTX)
TipRanks Financial Blog In a report released today, Benjamin Burnett from Stifel Nicolaus maintained a Buy rating on Repare Therapeutics (RPTX - Research Report), with a p...\n more…
Strategic Restructuring and Promising Pipeline Underpin Buy Rating for Repare Therapeutics
TipRanks Financial Blog In a report released today, Charles Zhu from LifeSci Capital maintained a Buy rating on Repare Therapeutics (RPTX - Research Report), with a price ...\n more…